Immunotherapeutic potential of bispecific antibodies
JGJ van de Winkel, B Bast, GC de Gast - Immunology today, 1997 - cell.com
JGJ van de Winkel, B Bast, GC de Gast
Immunology today, 1997•cell.comBispecific antibodies (BsAbs) offer therapeutic potential by targeting tumors or pathogens as
well as cytotoxic effector and/or antigen-presenting cells. A recent meeting∗∗ The Vth World
Conference on Bispecific Antibodies was held at Volendam, The Netherlands, on 25–28
June 1997. focused on current issues in the BsAb field.
well as cytotoxic effector and/or antigen-presenting cells. A recent meeting∗∗ The Vth World
Conference on Bispecific Antibodies was held at Volendam, The Netherlands, on 25–28
June 1997. focused on current issues in the BsAb field.
Abstract
Bispecific antibodies (BsAbs) offer therapeutic potential by targeting tumors or pathogens as well as cytotoxic effector and/or antigen-presenting cells. A recent meeting∗∗The Vth World Conference on Bispecific Antibodies was held at Volendam, The Netherlands, on 25–28 June 1997. focused on current issues in the BsAb field.
cell.com